Beth Israel Deaconess Medical Center (BIDMC) Harvard Medical School is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Beth Israel Deaconess Medical Center (BIDMC) Harvard Medical School has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID).
Sponsors: Regeneron Pharmaceuticals.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Beth Israel Deaconess Medical Center (BIDMC) Harvard Medical School has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Beth Israel Deaconess Medical Center (BIDMC) Harvard Medical School has 1 clinical trials on record, with 1 currently active. Their work covers Eosinophilic Gastritis (EoG), Eosinophilic Duodenitis (EoD), Eosinophilic Gastrointestinal Disease (EGID).
Beth Israel Deaconess Medical Center (BIDMC) Harvard Medical School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.